(Q77369404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

1 reference

1 reference

Klaus H W Boeker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Christian I Haberkorn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Dirk Michels

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Peer Flemming

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Michael P Manns

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Ralf Lichtinghagen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 February 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

71-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Hepatitis C virus infection: quality of life and side effects of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

The natural course of chronic hepatitis C: implications for clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Histological grading and staging of chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900730-6

10.1016/S0009-8981(01)00730-6

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11750276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference